Appili Therapeutics Inc. (APLIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0220
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Appili Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2017 - 2019 |
Net Income | -3.96 | -3.78 | -9.24 | -25.12 | -14.33 | -5.42 | Upgrade
|
Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
Loss (Gain) From Sale of Assets | -0 | -0 | 0.02 | 0 | 0 | - | Upgrade
|
Stock-Based Compensation | 0.12 | 0.19 | 0.88 | 2.04 | 1.17 | 0.6 | Upgrade
|
Other Operating Activities | 2.79 | 0.45 | 1.47 | 1.5 | 0.04 | 0.03 | Upgrade
|
Change in Accounts Receivable | -0.69 | -1.04 | 0.35 | 0.57 | -0.86 | 0.15 | Upgrade
|
Change in Inventory | - | - | - | - | 0.04 | 0.07 | Upgrade
|
Change in Accounts Payable | 0.96 | 1.38 | -4.16 | 1.92 | 3.21 | 0.02 | Upgrade
|
Change in Other Net Operating Assets | 0.1 | 0.04 | -0.05 | 0.27 | -0.23 | 0.06 | Upgrade
|
Operating Cash Flow | -0.62 | -2.46 | -10.1 | -19.08 | -11.45 | -4.26 | Upgrade
|
Capital Expenditures | -0 | -0.03 | -0 | - | -0.01 | -0 | Upgrade
|
Sale of Property, Plant & Equipment | 0 | 0 | - | - | - | - | Upgrade
|
Investment in Securities | - | - | - | 5.06 | -4.98 | -0 | Upgrade
|
Investing Cash Flow | -0 | -0.03 | -0 | 5.06 | -4.99 | -0 | Upgrade
|
Long-Term Debt Issued | - | 0.3 | 2.5 | 8 | - | 0.24 | Upgrade
|
Long-Term Debt Repaid | - | -0.1 | -0.09 | -4.17 | -0.02 | -0.05 | Upgrade
|
Net Debt Issued (Repaid) | 0.28 | 0.2 | 2.41 | 3.83 | -0.02 | 0.19 | Upgrade
|
Issuance of Common Stock | - | - | 3.21 | 5.39 | 14.56 | 7.99 | Upgrade
|
Other Financing Activities | -0.07 | -0.08 | 0.28 | 0.35 | 2.47 | 1.18 | Upgrade
|
Financing Cash Flow | 0.2 | 0.12 | 5.91 | 9.56 | 17.02 | 9.36 | Upgrade
|
Foreign Exchange Rate Adjustments | 0 | 0 | -0.01 | 0.06 | -0.02 | -0.01 | Upgrade
|
Net Cash Flow | -0.42 | -2.37 | -4.2 | -4.4 | 0.55 | 5.09 | Upgrade
|
Free Cash Flow | -0.62 | -2.49 | -10.1 | -19.08 | -11.46 | -4.26 | Upgrade
|
Free Cash Flow Margin | -500.59% | -301.44% | -3022.65% | -1372.07% | - | -2140.26% | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.02 | -0.09 | -0.29 | -0.19 | -0.12 | Upgrade
|
Cash Interest Paid | 0.35 | 1.1 | 0.48 | 0.09 | 0.02 | 0.07 | Upgrade
|
Cash Income Tax Paid | 0.06 | 0.06 | 0.01 | - | - | - | Upgrade
|
Levered Free Cash Flow | -7.67 | -5.22 | -7.37 | -11.74 | -7.04 | -2.47 | Upgrade
|
Unlevered Free Cash Flow | -6.01 | -4.2 | -6.77 | -10.77 | -6.97 | -2.46 | Upgrade
|
Change in Net Working Capital | -0.09 | -0.65 | 2.79 | -2.6 | -1.64 | -0.76 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.